📰 Euronext News
Page 4 - Euronext News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Euronext. Real-time updates on events, politics, business and more.
May 31, 2024
Dupixent recommended for EU approval by the CHMP to treat patients with COPD Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3...
May 31, 2024
TARRYTOWN, N.Y. and PARIS, May 31, 2024 -- Regeneron Pharmaceuticals, Inc. and Sanofi today announced the U.S. Food and Drug Administration has extended by three months the target action date of...
May 31, 2024
Dupixent recommended for EU approval by the CHMP to treat patients with COPD Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3
May 31, 2024
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food a
May 31, 2024
Tetragon has released its Monthly Factsheet for April 2024. - Net Asset Value: $ 2,780m- Fully Diluted NAV Per Share: $31.28- Share Price (TFG NA): $9.86- Monthly NAV per share total return: 1.1%- Monthly Return on Equity: -0.6%- Most recent...
May 31, 2024
Euronav - Special General Meeting & Extraordinary General Meeting of 2 July 2024 31 May 2024 08:00 CEST ...
May 31, 2024
FDE confirms 2026 targets and issue new guidance for 2030 Pontpierre, France, 31 May 2024 - FDE , a carbon-negative energy producer, is proud to confirm its 2026 objectives and to issue a new...
May 31, 2024
Euronext announced the resumption of trading in Neoen shares this morning at 9am. The stock was suspended at the companys request, following the announcement of Brookfields takeover offer.Neoen...
May 31, 2024
FINAL TERMS PROHIBITION OF SALES TO EEA RETAIL INVESTORS - Other than with respect to offers or sales of the Notes, or the Notes otherwise being made available,...
May 31, 2024
FINAL TERMS PROHIBITION OF SALES TO EEA RETAIL INVESTORS - Other than with respect to offers or sales of the Notes, or the Notes otherwise being made available,...